Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    1942
    PDF: 895
    HTML: 275
  • the EARLY TREATMENT WITH BAMLANIVIMAB ALONE DOES NOT PREVENT COVID-19 HOSPITALIZATION AND ITS POST-ACUTE SEQUELAE. A REAL EXPERIENCE IN UMBRIA, ITALY.

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Laura Martinelli Martinelli, lisa malincarne, Martina Savoia, Anna Laura Spinelli, Daniela Francisci
    e2021061
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.061
    1137
    PDF: 368
    HTML: 162
  • SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.

    Ilhami Berber, Ozlem Cagasar, Ahmet Sarıcı, Nurcan Kirici Berber, Ismet Aydogdu, Asli Yildirim, Harika Gozde Gocukara Bag, Leman Acun Delen, Ozkan Ulutas
    e2021009
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.009
    3091
    PDF: 1002
    HTML: 411
  • PRE AND POST-MONOCLONAL INFUSION NEUTRALIZING ACTIVITY IN A SUBGROUP OF PATIENTS TREATED IN THE PRESENCE OF TWO SARS-COV-2 DOMINANT VARIANT OF CONCERN (VOCS) AND AN ONGOING VACCINATION. OVERALL CLINICAL EFFICACY OF TWO MONOCLONAL ANTIBODIES ASSOCIATION IN UMBRIA

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Anna Gidari, Lisa Malincarne, Sara Benedetti , Alessandra Lanzi, Sabrina Bastianelli, Sara Pierucci, Chiara busti, Daniela Francisci
    e2022050
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.050
    1523
    PDF: 496
    HTML: 202
  • THE IMPACT OF THE SARS-CoV-2 PANDEMIC ON HEALTHCARE PROVISION IN ITALY TO NON-COVID PATIENTS: A SYSTEMATIC REVIEW

    Annarita Botta, Gianmarco Lugli, Matteo Maria Ottaviani, Guido Ascione, Alessandro Bruschi, Federico Cagnazzo, Lorenzo Zammarchi, Paola Romagnani, tommaso portaluri
    e2022012
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.012
    1671
    PDF: 2039
    HTML: 337
  • MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19

    XiaoTian Zhang, Yanhui Yu, Chao Zhang, Lijuan Zhao, Hongrui Wang, Guoqing Wang, Ming Yang
    e2022003
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.003
    1784
    PDF: 1011
    HTML: 269
  • TYPICAL AND ATYPICAL PRESENTATION OF COVID-19 INFECTION IN CHILDREN IN THE TOP OF PANDEMIC IN MINIA GOVERNORATE (TWO CENTER EXPERIENCE)

    Madeha Abdalla Sayed, Mohamed Abdelhakeem
    e2022002
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.002
    1478
    PDF: 552
    HTML: 236
  • COMPARISON OF THE CLINICAL AND LABORATORY FEATURES OF COVID AND INFLUENZA IN CHILDREN

    Davide Pata, Danilo Buonsenso, Piero Valentini
    e2022065
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.065
    1020
    PDF: 768
    HTML: 195
  • A MULTICENTRE ICET-A STUDY OF CONFIRMED SARS-COV-2 INFECTION IN PATIENTS WITH HEMOGLOBINOPATHIES: PRELIMINARY DATA FROM 10 COUNTRIES

    Vincenzo De Sanctis
    e2020046
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.046
    2653
    PDF: 1531
    HTML: 286
  • ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19

    Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam
    e2022036
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.036
    784
    PDF: 476
    HTML: 346
  • Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

    Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team
    e2024043
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.043
    1194
    PDF: 894
    HTML: 80
  • The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients

    Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim
    e2020082
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.082
    885
    PDF: 323
    HTML: 161
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    2266
    PDF: 869
    HTML: 462
  • IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

    İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
    e2022074
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.074
    1334
    PDF: 704
    HTML: 189
  • Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

    Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese
    e2023007
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.007
    798
    PDF: 888
    HTML: 377
  • The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases

    Laila Al Yazidi
    e2020074
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.074
    755
    PDF: 657
    HTML: 288
  • CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children

    Giuseppe Lassandro, Valentina  Palladino, Anna Amoruso, Viviana Palmieri, Giovanna Russo, Paola Giordano
    e2020042
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.042
    1334
    PDF: 900
    HTML: 280
  • THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

    Nicola Semeraro, Prof. Mario Colucci
    e2021045
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.045
    1846
    PDF: 762
    HTML: 204
  • Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients

    Alexandre Malek
    e2020044
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.044
    1123
    PDF: 743
    HTML: 205
  • Management of pediatric rheumatological diseases during the outbreak of COVID-19: our experience

    Romina Gallizzi, Diana Sutera, Francesca Mazza, Alessandra Spagnolo, Giovanni Battista Pajno
    e2020049
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.049
    982
    PDF: 660
    HTML: 174
  • Delivery in asymptomatic Italian woman with SARS-CoV-2 infection. Delivery in asymptomatic woman with SARS-CoV-2 infection

    Giuseppe Vittorio De Socio, Lisa Malincarne, Saverio Arena, Stefania Troiani, Sara Benedetti, Barbara Camilloni, Giorgio Epicoco, Antonella Mencacci, Daniela Francisci
    e2020033
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.033
    1721
    PDF: 932
    HTML: 209
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    660
    PDF: 521
    HTML: 19
  • Immune Biomarker Signature in the Diagnostic Workup of Fever Without Source: A Pilot Study

    Angela Maria Di Francesco, Giuliana Pasciuto, Laura Gerardino, Ludovico Luca Sicignano, Elena Verrecchia, Andrea Urbani, Donato Rigante, Raffaele Manna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.030
    389
    PDF: 223
    HTML: 82
  • Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy.

    Stefano Molica, Paolo Sportoletti, Nicola Di Renzo, Pellegrino Musto, Fabrizio Pane, Francesco Di Raimondo
    e2021042
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.042
    1159
    PDF: 423
    HTML: 184
  • Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

    Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.029
    333
    PDF: 198
    HTML: 52
  • Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients

    NICOLA SGHERZA, Stefania Zucano, Angelantonio Vitucci, Antonio Palma, Francesco Tarantini, Daniela Campanale, Luigi Vimercati, Angela Maria Vittoria Larocca, Domenico Visceglie, Amalia Acquafredda, Angelo Ostuni, Daniela Di Gennaro, Carmen Vitucci, Silvio Tafuri, Pellegrino Musto
    e2022056
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.056
    924
    HTML: 257
    PDF: 473
1 - 26 of 26 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy